Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1974 Jun;71(6):2319–2323. doi: 10.1073/pnas.71.6.2319

Effects of Dialyzable Transfer Factor in Patients with Breast Cancer

H F Oettgen *, L J Old *, J H Farrow *, F T Valentine †, H S Lawrence †, L Thomas *
PMCID: PMC388444  PMID: 4366760

Abstract

Five patients with advanced breast cancer were treated with pooled dialyzable transfer factor from healthy adult donors. The period of treatment ranged from 21 to 310 days, the total dose from 20 to 257 ml. Transfer factor did not elicit inflammatory or hypersensitivity reactions or detectable formation of antibody to itself, nor any hematological or biochemical abnormalities or other side effects. Three patients became responsive (by skin test) to tuberculin and/or streptococcal antigens. Marked partial regression of the breast cancer, lasting 6 months, was observed in one patient.

Keywords: immunology, delayed hypersensitivity

Full text

PDF
2319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brandes L. J., Galton D. A., Wiltshaw E. New approach to immunotherapy of melanoma. Lancet. 1971 Aug 7;2(7719):293–295. doi: 10.1016/s0140-6736(71)91336-5. [DOI] [PubMed] [Google Scholar]
  2. Brown R. E., Katz M. Passive transfer of delayed hypersensitivity reaction to tuberculin in children with protein calorie malnutrition. J Pediatr. 1967 Jan;70(1):126–128. doi: 10.1016/s0022-3476(67)80178-1. [DOI] [PubMed] [Google Scholar]
  3. DELORME E. J., ALEXANDER P. TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTES. Lancet. 1964 Jul 18;2(7351):117–120. doi: 10.1016/s0140-6736(64)90126-6. [DOI] [PubMed] [Google Scholar]
  4. Graybill J. R., Silva J., Jr, Alford R. H., Thor D. E. Immunologic and clinical improvement of progressive coccidioidomycosis following administration of transfer factor. Cell Immunol. 1973 Jul;8(1):120–135. doi: 10.1016/0008-8749(73)90099-3. [DOI] [PubMed] [Google Scholar]
  5. Kirkpatrick C. H., Chandler J. W., Schimke R. N. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol. 1970 Mar;6(3):375–385. [PMC free article] [PubMed] [Google Scholar]
  6. Lawrence H. S. Transfer factor and cellular immune deficiency disease. N Engl J Med. 1970 Aug 20;283(8):411–419. doi: 10.1056/NEJM197008202830809. [DOI] [PubMed] [Google Scholar]
  7. Lawrence H. S., Zweiman B. Transfer factor deficiency response--a mechanism of anergy in Boeck's sarcoid. Trans Assoc Am Physicians. 1968;81:240–248. [PubMed] [Google Scholar]
  8. Levin A. S., Spitler L. E., Stites D. P., Fudenberg H. H. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A. 1970 Oct;67(2):821–828. doi: 10.1073/pnas.67.2.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nadler S. H., Moore G. E. Immunotherapy of malignant melanoma. Geriatrics. 1968 May;23(5):150–153. [PubMed] [Google Scholar]
  10. Niederman J. C., Evans A. S., Subrahmanyan L., McCollum R. W. Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med. 1970 Feb 12;282(7):361–365. doi: 10.1056/NEJM197002122820704. [DOI] [PubMed] [Google Scholar]
  11. Old L. J., Boyse E. A., Oettgen H. F., Harven E. D., Geering G., Williamson B., Clifford P. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699–1704. doi: 10.1073/pnas.56.6.1699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rocklin R. E., Chilgren R. A., Hong R., David J. R. Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol. 1970 Sep;1(3):290–299. doi: 10.1016/0008-8749(70)90050-x. [DOI] [PubMed] [Google Scholar]
  13. Schulking M. L., Adler W. H., 3rd, Altemeier W. A., 3rd, Ayoub E. M. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell Immunol. 1972 Apr;3(4):606–615. doi: 10.1016/0008-8749(72)90122-0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES